Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α

Spatiotemporal regulation of tumor immunity remains largely unexplored. Here we identify a vascular niche that controls alternative macrophage activation in glioblastoma (GBM). We show that tumor-promoting macrophages are spatially proximate to GBM-associated endothelial cells (ECs), permissive for...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 9; no. 1; pp. 559 - 15
Main Authors Wang, Qirui, He, Zhenqiang, Huang, Menggui, Liu, Tianrun, Wang, Yanling, Xu, Haineng, Duan, Hao, Ma, Peihong, Zhang, Lin, Zamvil, Scott S., Hidalgo, Juan, Zhang, Zhenfeng, O’Rourke, Donald M., Dahmane, Nadia, Brem, Steven, Mou, Yonggao, Gong, Yanqing, Fan, Yi
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 08.02.2018
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Spatiotemporal regulation of tumor immunity remains largely unexplored. Here we identify a vascular niche that controls alternative macrophage activation in glioblastoma (GBM). We show that tumor-promoting macrophages are spatially proximate to GBM-associated endothelial cells (ECs), permissive for angiocrine-induced macrophage polarization. We identify ECs as one of the major sources for interleukin-6 (IL-6) expression in GBM microenvironment. Furthermore, we reveal that colony-stimulating factor-1 and angiocrine IL-6 induce robust arginase-1 expression and macrophage alternative activation, mediated through peroxisome proliferator-activated receptor-γ-dependent transcriptional activation of hypoxia-inducible factor-2α. Finally, utilizing a genetic murine GBM model, we show that EC-specific knockout of IL-6 inhibits macrophage alternative activation and improves survival in the GBM-bearing mice. These findings illustrate a vascular niche-dependent mechanism for alternative macrophage activation and cancer progression, and suggest that targeting endothelial IL-6 may offer a selective and efficient therapeutic strategy for GBM, and possibly other solid malignant tumors. Macrophages in the tumour microenvironment (TME) acquire tumour-promoting functions upon M2 polarization. Here the authors show, in a mouse model of glioblastoma, that endothelial cells in the TME induce macrophage M2 polarization via IL-6 and that depletion of endothelial IL-6 improves survival.
AbstractList Spatiotemporal regulation of tumor immunity remains largely unexplored. Here we identify a vascular niche that controls alternative macrophage activation in glioblastoma (GBM). We show that tumor-promoting macrophages are spatially proximate to GBM-associated endothelial cells (ECs), permissive for angiocrine-induced macrophage polarization. We identify ECs as one of the major sources for interleukin-6 (IL-6) expression in GBM microenvironment. Furthermore, we reveal that colony-stimulating factor-1 and angiocrine IL-6 induce robust arginase-1 expression and macrophage alternative activation, mediated through peroxisome proliferator-activated receptor-γ-dependent transcriptional activation of hypoxia-inducible factor-2α. Finally, utilizing a genetic murine GBM model, we show that EC-specific knockout of IL-6 inhibits macrophage alternative activation and improves survival in the GBM-bearing mice. These findings illustrate a vascular niche-dependent mechanism for alternative macrophage activation and cancer progression, and suggest that targeting endothelial IL-6 may offer a selective and efficient therapeutic strategy for GBM, and possibly other solid malignant tumors.
Spatiotemporal regulation of tumor immunity remains largely unexplored. Here we identify a vascular niche that controls alternative macrophage activation in glioblastoma (GBM). We show that tumor-promoting macrophages are spatially proximate to GBM-associated endothelial cells (ECs), permissive for angiocrine-induced macrophage polarization. We identify ECs as one of the major sources for interleukin-6 (IL-6) expression in GBM microenvironment. Furthermore, we reveal that colony-stimulating factor-1 and angiocrine IL-6 induce robust arginase-1 expression and macrophage alternative activation, mediated through peroxisome proliferator-activated receptor-γ-dependent transcriptional activation of hypoxia-inducible factor-2α. Finally, utilizing a genetic murine GBM model, we show that EC-specific knockout of IL-6 inhibits macrophage alternative activation and improves survival in the GBM-bearing mice. These findings illustrate a vascular niche-dependent mechanism for alternative macrophage activation and cancer progression, and suggest that targeting endothelial IL-6 may offer a selective and efficient therapeutic strategy for GBM, and possibly other solid malignant tumors. Macrophages in the tumour microenvironment (TME) acquire tumour-promoting functions upon M2 polarization. Here the authors show, in a mouse model of glioblastoma, that endothelial cells in the TME induce macrophage M2 polarization via IL-6 and that depletion of endothelial IL-6 improves survival.
Spatiotemporal regulation of tumor immunity remains largely unexplored. Here we identify a vascular niche that controls alternative macrophage activation in glioblastoma (GBM). We show that tumor-promoting macrophages are spatially proximate to GBM-associated endothelial cells (ECs), permissive for angiocrine-induced macrophage polarization. We identify ECs as one of the major sources for interleukin-6 (IL-6) expression in GBM microenvironment. Furthermore, we reveal that colony-stimulating factor-1 and angiocrine IL-6 induce robust arginase-1 expression and macrophage alternative activation, mediated through peroxisome proliferator-activated receptor-γ-dependent transcriptional activation of hypoxia-inducible factor-2α. Finally, utilizing a genetic murine GBM model, we show that EC-specific knockout of IL-6 inhibits macrophage alternative activation and improves survival in the GBM-bearing mice. These findings illustrate a vascular niche-dependent mechanism for alternative macrophage activation and cancer progression, and suggest that targeting endothelial IL-6 may offer a selective and efficient therapeutic strategy for GBM, and possibly other solid malignant tumors.Macrophages in the tumour microenvironment (TME) acquire tumour-promoting functions upon M2 polarization. Here the authors show, in a mouse model of glioblastoma, that endothelial cells in the TME induce macrophage M2 polarization via IL-6 and that depletion of endothelial IL-6 improves survival.
Macrophages in the tumour microenvironment (TME) acquire tumour-promoting functions upon M2 polarization. Here the authors show, in a mouse model of glioblastoma, that endothelial cells in the TME induce macrophage M2 polarization via IL-6 and that depletion of endothelial IL-6 improves survival.
Spatiotemporal regulation of tumor immunity remains largely unexplored. Here we identify a vascular niche that controls alternative macrophage activation in glioblastoma (GBM). We show that tumor-promoting macrophages are spatially proximate to GBM-associated endothelial cells (ECs), permissive for angiocrine-induced macrophage polarization. We identify ECs as one of the major sources for interleukin-6 (IL-6) expression in GBM microenvironment. Furthermore, we reveal that colony-stimulating factor-1 and angiocrine IL-6 induce robust arginase-1 expression and macrophage alternative activation, mediated through peroxisome proliferator-activated receptor-γ-dependent transcriptional activation of hypoxia-inducible factor-2α. Finally, utilizing a genetic murine GBM model, we show that EC-specific knockout of IL-6 inhibits macrophage alternative activation and improves survival in the GBM-bearing mice. These findings illustrate a vascular niche-dependent mechanism for alternative macrophage activation and cancer progression, and suggest that targeting endothelial IL-6 may offer a selective and efficient therapeutic strategy for GBM, and possibly other solid malignant tumors.Spatiotemporal regulation of tumor immunity remains largely unexplored. Here we identify a vascular niche that controls alternative macrophage activation in glioblastoma (GBM). We show that tumor-promoting macrophages are spatially proximate to GBM-associated endothelial cells (ECs), permissive for angiocrine-induced macrophage polarization. We identify ECs as one of the major sources for interleukin-6 (IL-6) expression in GBM microenvironment. Furthermore, we reveal that colony-stimulating factor-1 and angiocrine IL-6 induce robust arginase-1 expression and macrophage alternative activation, mediated through peroxisome proliferator-activated receptor-γ-dependent transcriptional activation of hypoxia-inducible factor-2α. Finally, utilizing a genetic murine GBM model, we show that EC-specific knockout of IL-6 inhibits macrophage alternative activation and improves survival in the GBM-bearing mice. These findings illustrate a vascular niche-dependent mechanism for alternative macrophage activation and cancer progression, and suggest that targeting endothelial IL-6 may offer a selective and efficient therapeutic strategy for GBM, and possibly other solid malignant tumors.
ArticleNumber 559
Author Duan, Hao
Hidalgo, Juan
Ma, Peihong
Wang, Yanling
Gong, Yanqing
Fan, Yi
Zhang, Lin
Huang, Menggui
Dahmane, Nadia
He, Zhenqiang
Zamvil, Scott S.
Wang, Qirui
Xu, Haineng
Brem, Steven
Liu, Tianrun
Mou, Yonggao
Zhang, Zhenfeng
O’Rourke, Donald M.
Author_xml – sequence: 1
  givenname: Qirui
  surname: Wang
  fullname: Wang, Qirui
  organization: Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, School of Traditional Chinese Medicine, Southern Medical University
– sequence: 2
  givenname: Zhenqiang
  surname: He
  fullname: He, Zhenqiang
  organization: Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Department of Neurosurgery, Sun Yat-sen University Cancer Center
– sequence: 3
  givenname: Menggui
  surname: Huang
  fullname: Huang, Menggui
  organization: Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine
– sequence: 4
  givenname: Tianrun
  surname: Liu
  fullname: Liu, Tianrun
  organization: Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Department of Otorhinolaryngology, Division of Head and Neck Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University
– sequence: 5
  givenname: Yanling
  surname: Wang
  fullname: Wang, Yanling
  organization: Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine
– sequence: 6
  givenname: Haineng
  surname: Xu
  fullname: Xu, Haineng
  organization: Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine
– sequence: 7
  givenname: Hao
  surname: Duan
  fullname: Duan, Hao
  organization: Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Department of Neurosurgery, Sun Yat-sen University Cancer Center
– sequence: 8
  givenname: Peihong
  surname: Ma
  fullname: Ma, Peihong
  organization: Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine
– sequence: 9
  givenname: Lin
  orcidid: 0000-0003-1998-0611
  surname: Zhang
  fullname: Zhang, Lin
  organization: Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine
– sequence: 10
  givenname: Scott S.
  surname: Zamvil
  fullname: Zamvil, Scott S.
  organization: Department of Neurology and Program in Immunology, University of California at San Francisco
– sequence: 11
  givenname: Juan
  orcidid: 0000-0003-0921-1122
  surname: Hidalgo
  fullname: Hidalgo, Juan
  organization: Department of Cellular Biology, Physiology, and Immunology, Autonomous University of Barcelona
– sequence: 12
  givenname: Zhenfeng
  orcidid: 0000-0001-5621-9755
  surname: Zhang
  fullname: Zhang, Zhenfeng
  organization: Department of Radiology The, Second Affiliated Hospital of Guangzhou Medical University
– sequence: 13
  givenname: Donald M.
  surname: O’Rourke
  fullname: O’Rourke, Donald M.
  organization: Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine
– sequence: 14
  givenname: Nadia
  surname: Dahmane
  fullname: Dahmane, Nadia
  organization: Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine
– sequence: 15
  givenname: Steven
  surname: Brem
  fullname: Brem, Steven
  organization: Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine
– sequence: 16
  givenname: Yonggao
  surname: Mou
  fullname: Mou, Yonggao
  organization: Department of Neurosurgery, Sun Yat-sen University Cancer Center
– sequence: 17
  givenname: Yanqing
  surname: Gong
  fullname: Gong, Yanqing
  organization: Department of Medicine, Division of Human Genetics and Translational Medicine, University of Pennsylvania Perelman School of Medicine
– sequence: 18
  givenname: Yi
  surname: Fan
  fullname: Fan, Yi
  email: fanyi@uphs.upenn.edu
  organization: Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29422647$$D View this record in MEDLINE/PubMed
BookMark eNp9kt9uFCEUxompsXXtC3hhJvHGm1H-DTA3JqaxdpNNvFHvDDkDzCwbdlhhpkkfyxfxmaS7tdk2sVwAOfy-jwPnvEQnYxwdQq8Jfk8wUx8yJ1zIGhNVY4YbXONn6IxiTmoiKTs52p-i85w3uAzWEsX5C3RKW06p4PIM_fwB2cwBUjV6s3bVclWLyo92Ni5XECaXRpj8tau2YFLcrWFwFZgSKdE4FrIago9dgDzFLVTTOsV5WFdXy8ua_vn9Cj3vIWR3frcu0PfLz98ururV1y_Li0-r2jRCTTUxxFohmZJCkU4oCh23oFxvucXQNdBhh1tHnAVmKSbCKmYwJVwaq4wgbIGWB18bYaN3yW8h3egIXu8DMQ0a0uRNcLrpmQQrJXR9ww13qjVOEUIsp4qBkcXr48FrN3dbZ40bpwThgenDk9Gv9RCvdaNwIxkvBu_uDFL8Nbs86a3PxoUAo4tz1hRjgkXDJCvo20foJs7lx0OhWsIYKUVWT1GkbVshylfcUm-O875P-F-tC0APQClkzsn19wjB-ran9KGndOkpve-pMi-QeiQyftrXvrzdh6el7CDN5Z5xcOko7f-r_gLfUd-w
CitedBy_id crossref_primary_10_1016_j_cmet_2019_06_001
crossref_primary_10_1080_2162402X_2024_2352179
crossref_primary_10_1111_febs_15726
crossref_primary_10_2147_NDT_S318919
crossref_primary_10_1016_j_semcancer_2022_05_003
crossref_primary_10_1089_ars_2022_0004
crossref_primary_10_2174_0113816128268963231013074433
crossref_primary_10_1126_scitranslmed_aay7522
crossref_primary_10_1007_s11060_018_03010_0
crossref_primary_10_1016_j_acthis_2023_152070
crossref_primary_10_3389_fonc_2018_00549
crossref_primary_10_1158_2326_6066_CIR_21_1050
crossref_primary_10_1166_jbn_2021_3160
crossref_primary_10_4236_jbm_2023_118009
crossref_primary_10_1186_s13046_018_0938_5
crossref_primary_10_18632_aging_202276
crossref_primary_10_1002_jcp_28197
crossref_primary_10_3390_cancers16050890
crossref_primary_10_3390_ijms22052662
crossref_primary_10_3390_metabo12030243
crossref_primary_10_1007_s11912_023_01417_1
crossref_primary_10_1186_s12935_021_01982_0
crossref_primary_10_1016_j_mvr_2023_104506
crossref_primary_10_1186_s13045_024_01544_7
crossref_primary_10_1016_j_semcancer_2024_07_005
crossref_primary_10_1016_j_semcancer_2022_11_003
crossref_primary_10_3389_fcell_2020_607209
crossref_primary_10_1016_j_jallcom_2022_164694
crossref_primary_10_1101_cshperspect_a041411
crossref_primary_10_1038_s41389_019_0166_7
crossref_primary_10_3389_fphar_2020_00368
crossref_primary_10_7717_peerj_9038
crossref_primary_10_5662_wjm_v12_i5_428
crossref_primary_10_1016_j_immuni_2019_03_027
crossref_primary_10_1158_1078_0432_CCR_18_2402
crossref_primary_10_3389_fcell_2020_00056
crossref_primary_10_1016_j_bbih_2024_100859
crossref_primary_10_1016_j_trecan_2019_05_007
crossref_primary_10_1166_jbt_2022_2886
crossref_primary_10_1002_1878_0261_12569
crossref_primary_10_1007_s10555_024_10211_9
crossref_primary_10_3389_fonc_2022_822085
crossref_primary_10_1021_acs_nanolett_9b00237
crossref_primary_10_1126_scitranslmed_aay1371
crossref_primary_10_1080_14728222_2021_1881062
crossref_primary_10_1172_JCI163446
crossref_primary_10_3389_fonc_2022_961753
crossref_primary_10_1016_j_intimp_2024_113315
crossref_primary_10_3389_fimmu_2024_1384249
crossref_primary_10_3390_ijms22010351
crossref_primary_10_1093_neuros_nyab280
crossref_primary_10_1016_j_tranon_2021_101038
crossref_primary_10_1016_j_neurol_2023_03_007
crossref_primary_10_1016_j_omto_2021_08_008
crossref_primary_10_3390_cells14060413
crossref_primary_10_1126_scitranslmed_abj5070
crossref_primary_10_1242_dev_200030
crossref_primary_10_4081_btvb_2024_116
crossref_primary_10_1093_neuros_nyab288
crossref_primary_10_1158_0008_5472_CAN_21_0345
crossref_primary_10_3389_fonc_2024_1454370
crossref_primary_10_3390_curroncol32010016
crossref_primary_10_3390_ijms23042313
crossref_primary_10_1016_j_trecan_2018_11_002
crossref_primary_10_1146_annurev_physiol_020518_114721
crossref_primary_10_3389_fimmu_2020_585616
crossref_primary_10_1016_j_trecan_2023_08_002
crossref_primary_10_1111_febs_15669
crossref_primary_10_3390_cancers15092613
crossref_primary_10_1002_jbt_23719
crossref_primary_10_18632_aging_205120
crossref_primary_10_1038_s41467_018_05982_z
crossref_primary_10_3390_cancers14061452
crossref_primary_10_1016_j_celrep_2025_115432
crossref_primary_10_1016_j_cmet_2023_01_010
crossref_primary_10_1016_j_oraloncology_2020_104723
crossref_primary_10_1186_s12885_021_09004_y
crossref_primary_10_3389_fonc_2023_1063051
crossref_primary_10_3389_fimmu_2020_01308
crossref_primary_10_3389_fphar_2024_1384721
crossref_primary_10_3389_fimmu_2021_646043
crossref_primary_10_1186_s11658_023_00432_1
crossref_primary_10_1038_s41598_024_60347_5
crossref_primary_10_3389_fonc_2021_669071
crossref_primary_10_1038_s41388_021_02010_1
crossref_primary_10_1073_pnas_2206208119
crossref_primary_10_3390_cells10030607
crossref_primary_10_3390_cells11101682
crossref_primary_10_1016_j_isci_2022_105329
crossref_primary_10_1016_j_semcancer_2018_06_002
crossref_primary_10_1002_advs_202306359
crossref_primary_10_3390_ijms23126697
crossref_primary_10_1021_acsnano_2c08861
crossref_primary_10_1038_s41598_024_51427_7
crossref_primary_10_1038_s42003_024_07134_0
crossref_primary_10_1007_s00018_025_05642_8
crossref_primary_10_3390_coatings12111742
crossref_primary_10_1007_s10143_024_02823_0
crossref_primary_10_1016_j_phymed_2023_154764
crossref_primary_10_1016_j_jconrel_2022_11_024
crossref_primary_10_3390_ijms232415612
crossref_primary_10_1016_j_canlet_2019_03_015
crossref_primary_10_1007_s12032_024_02434_1
crossref_primary_10_3390_oxygen3010005
crossref_primary_10_1007_s10143_024_02783_5
crossref_primary_10_3390_ijms221910665
crossref_primary_10_4049_jimmunol_1801269
crossref_primary_10_1016_j_addr_2022_114585
crossref_primary_10_1097_CCO_0000000000000895
crossref_primary_10_3389_fcell_2021_706286
crossref_primary_10_1186_s13287_023_03381_w
crossref_primary_10_3390_cancers14030813
crossref_primary_10_1042_CS20201259
crossref_primary_10_1186_s40478_024_01757_4
crossref_primary_10_1016_j_apsb_2022_09_012
crossref_primary_10_1038_s43018_025_00905_6
crossref_primary_10_3389_fddev_2022_823412
crossref_primary_10_1016_j_critrevonc_2025_104649
crossref_primary_10_1016_j_jhepr_2024_101217
crossref_primary_10_1007_s10555_021_09958_2
crossref_primary_10_3390_cancers13112610
crossref_primary_10_1093_neuros_nyy268
crossref_primary_10_1161_CIRCULATIONAHA_124_070368
crossref_primary_10_3390_biomedicines10050986
crossref_primary_10_1016_j_molmed_2023_11_002
crossref_primary_10_1016_j_bbcan_2018_04_008
crossref_primary_10_1186_s12929_019_0580_3
crossref_primary_10_1007_s11060_023_04390_8
crossref_primary_10_1016_j_ceb_2023_102287
crossref_primary_10_1186_s12935_023_02970_2
crossref_primary_10_1038_s41598_022_07697_0
crossref_primary_10_37155_2972_4759_2024_02_01_1
crossref_primary_10_3389_fonc_2021_671044
crossref_primary_10_1016_j_bcp_2022_115369
crossref_primary_10_1021_acs_jmedchem_3c00332
crossref_primary_10_1038_s43018_020_00147_8
crossref_primary_10_3390_vaccines11010055
crossref_primary_10_1007_s13402_024_00931_z
crossref_primary_10_1126_sciadv_adj4678
crossref_primary_10_1016_j_phymed_2024_155714
crossref_primary_10_1016_j_tips_2022_04_002
crossref_primary_10_3389_fimmu_2021_811485
crossref_primary_10_1093_neuros_nyz528
crossref_primary_10_3389_fcell_2023_1125723
crossref_primary_10_1038_s41467_021_23832_3
crossref_primary_10_3390_ijms251910486
crossref_primary_10_3390_ijms22115775
crossref_primary_10_3390_cells12202510
crossref_primary_10_1016_j_biopha_2020_110086
crossref_primary_10_3233_CBM_230486
crossref_primary_10_3389_fimmu_2023_1333549
crossref_primary_10_3389_fphar_2023_1243675
crossref_primary_10_1002_cbin_11881
crossref_primary_10_1126_scitranslmed_abq3558
crossref_primary_10_1186_s13045_021_01103_4
crossref_primary_10_1186_s12951_023_01986_0
crossref_primary_10_4103_tcmj_tcmj_78_20
crossref_primary_10_3390_cancers11101511
crossref_primary_10_3389_fphar_2019_00286
crossref_primary_10_1007_s10571_019_00704_5
crossref_primary_10_1007_s11060_022_03947_3
crossref_primary_10_1016_j_imbio_2019_10_002
crossref_primary_10_1016_j_phymed_2022_154016
crossref_primary_10_1016_j_tranon_2024_102259
crossref_primary_10_1038_s41467_020_19540_z
crossref_primary_10_1177_10732748241290067
crossref_primary_10_1016_j_ejphar_2021_174438
crossref_primary_10_1111_jcmm_14973
crossref_primary_10_18632_oncotarget_26863
crossref_primary_10_3390_ijms242216206
crossref_primary_10_1007_s00330_022_09012_x
crossref_primary_10_1016_j_omto_2023_08_004
crossref_primary_10_1016_j_jconrel_2021_02_002
crossref_primary_10_1371_journal_pcbi_1007468
crossref_primary_10_1038_s42003_022_03402_z
crossref_primary_10_2147_CMAR_S475513
crossref_primary_10_3390_ijms21134733
crossref_primary_10_1080_2162402X_2024_2425124
crossref_primary_10_3389_fimmu_2020_580934
crossref_primary_10_1002_alr_22218
Cites_doi 10.1084/jem.185.3.461
10.1093/neuonc/not115
10.1016/j.cmet.2007.06.010
10.1002/path.2370
10.1016/j.stem.2010.01.001
10.1016/S1471-4906(02)02302-5
10.1016/j.tcm.2012.10.003
10.1038/nri3073
10.1002/path.4192
10.1182/blood-2012-04-422758
10.1038/labinvest.2011.128
10.1016/j.bbrc.2015.04.083
10.1038/sj.onc.1210683
10.1038/nm.2537
10.1038/nrc2442
10.1016/j.ccr.2006.11.020
10.1101/gad.1881410
10.1016/j.cell.2012.01.021
10.3171/jns.1979.50.3.0305
10.1111/j.1582-4934.2009.00963.x
10.1038/nn.4185
10.1038/nature04753
10.12703/P6-13
10.1016/j.ccr.2004.11.022
10.1007/s00401-013-1079-8
10.1038/nature11986
10.1158/1078-0432.CCR-12-1940
10.1093/brain/aww355
10.1038/nrc1256
10.1084/jem.176.1.287
10.1172/JCI45444
10.1056/NEJMoa043330
10.1038/34178
10.1038/ncb2954
10.1001/jama.2013.280319
10.1172/JCI57158
10.1016/j.it.2015.02.004
10.1016/j.jneuroim.2014.06.021
10.1038/nature10144
10.1038/ni.2865
10.1038/ncb2767
10.1172/JCI59643
10.1038/nrc2791
10.1038/nm1620
10.1038/ni.3153
10.1038/nature10525
10.1038/ncomms10539
10.1016/j.ccr.2012.12.021
10.1038/nature09002
10.1101/gad.187922.112
10.1084/jem.20130699
10.1016/j.cell.2007.04.019
10.1172/JCI84876
10.1161/ATVBAHA.113.301453
10.1038/sj.onc.1207455
10.1038/368339a0
10.1016/j.it.2012.07.003
10.1038/nri3088
10.1016/j.jocn.2004.11.017
10.1016/j.immuni.2010.11.009
10.2119/molmed.2011.00217
10.1016/j.ccr.2014.02.005
10.1016/j.ccell.2015.02.015
10.1016/j.febslet.2007.12.024
10.1016/j.bbi.2012.10.011
10.1016/j.immuni.2013.10.022
10.1038/nm.3337
10.1038/nature05894
10.1172/jci.insight.85841
ContentType Journal Article
Copyright The Author(s) 2018
2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2018
– notice: 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
SOI
7X8
5PM
DOA
DOI 10.1038/s41467-018-03050-0
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database (ProQuest)
Biological Science Database (ProQuest)
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

Publicly Available Content Database
Publicly Available Content Database

MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
Medicine
EISSN 2041-1723
EndPage 15
ExternalDocumentID oai_doaj_org_article_5f37ad77abf54c4e89ce8111d4283ac7
PMC5805734
29422647
10_1038_s41467_018_03050_0
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R00 HL103792
– fundername: NCI NIH HHS
  grantid: R01 CA190415
– fundername: NINDS NIH HHS
  grantid: R01 NS094533
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BAPOH
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LK8
M1P
M48
M7P
M~E
NAO
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
SOI
AARCD
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c568t-1c1dd67387681b682ab4da8efd4d0ab5ab0e09e1eda3d2016d83c02147cd8c613
IEDL.DBID M48
ISSN 2041-1723
IngestDate Wed Aug 27 01:30:51 EDT 2025
Thu Aug 21 13:57:25 EDT 2025
Fri Jul 11 04:18:45 EDT 2025
Wed Aug 13 04:33:48 EDT 2025
Sat Aug 23 13:10:22 EDT 2025
Wed Feb 19 02:23:15 EST 2025
Tue Jul 01 02:21:09 EDT 2025
Thu Apr 24 23:03:34 EDT 2025
Fri Feb 21 02:39:58 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c568t-1c1dd67387681b682ab4da8efd4d0ab5ab0e09e1eda3d2016d83c02147cd8c613
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-1998-0611
0000-0001-5621-9755
0000-0003-0921-1122
OpenAccessLink https://www.proquest.com/docview/2913314148?pq-origsite=%requestingapplication%
PMID 29422647
PQID 1999660218
PQPubID 546298
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_5f37ad77abf54c4e89ce8111d4283ac7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5805734
proquest_miscellaneous_2001065373
proquest_journals_2913314148
proquest_journals_1999660218
pubmed_primary_29422647
crossref_primary_10_1038_s41467_018_03050_0
crossref_citationtrail_10_1038_s41467_018_03050_0
springer_journals_10_1038_s41467_018_03050_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-02-08
PublicationDateYYYYMMDD 2018-02-08
PublicationDate_xml – month: 02
  year: 2018
  text: 2018-02-08
  day: 08
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2018
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Komohara, Ohnishi, Kuratsu, Takeya (CR42) 2008; 216
Martinez, Gordon (CR22) 2014; 6
Liao (CR64) 2011; 121
Semenza (CR30) 2012; 148
Tannahill (CR34) 2013; 496
Prosniak (CR23) 2013; 19
Sumbayev (CR31) 2008; 582
Weissenberger (CR54) 2004; 23
Chang (CR39) 2005; 12
Lawrence, Natoli (CR27) 2011; 11
Omuro, DeAngelis (CR9) 2013; 310
Wang, Hong, Hsueh, Chiang (CR20) 2012; 92
Huang (CR66) 2016; 126
Park (CR32) 2003; 9
Hunter, Jones (CR56) 2015; 16
Stein, Keshav, Harris, Gordon (CR6) 1992; 176
Morantz, Wood, Foster, Clark, Gollahon (CR11) 1979; 50
Lu (CR50) 2013; 23
Dunn (CR8) 2012; 26
Hamidian, von Stedingk, Munksgaard Thoren, Mohlin, Pahlman (CR65) 2015; 461
Tugal, Liao, Jain (CR24) 2013; 33
Selak (CR33) 2005; 7
Weis, Cheresh (CR51) 2011; 17
Vinnakota (CR18) 2013; 15
Poon, Sarkar, Yong, Kelly (CR14) 2017; 140
Beck (CR44) 2011; 478
Kopf (CR55) 1994; 368
Jones, Scheller, Rose-John (CR58) 2011; 121
Fielding (CR59) 2014; 40
Ruffell, Coussens (CR2) 2015; 27
Pyonteck (CR13) 2013; 19
Mazumdar, Dondeti, Simon (CR28) 2009; 13
CR43
He (CR53) 2012; 120
Takeda (CR36) 2010; 24
Calabrese (CR47) 2007; 11
Hambardzumyan, Gutmann, Kettenmann (CR12) 2016; 19
Carvalho da Fonseca (CR15) 2014; 274
Mantovani, Sozzani, Locati, Allavena, Sica (CR41) 2002; 23
Rincon, Anguita, Nakamura, Fikrig, Flavell (CR60) 1997; 185
Rincon (CR57) 2012; 33
Ku (CR21) 2013; 125
Fan (CR35) 2014; 16
Sielska (CR19) 2013; 230
Cao (CR52) 2014; 25
Ricote, Li, Willson, Kelly, Glass (CR62) 1998; 391
Bouhlel (CR38) 2007; 6
Carmeliet, Jain (CR48) 2011; 473
Szanto (CR63) 2010; 33
Butler, Kobayashi, Rafii (CR46) 2010; 10
Charles (CR40) 2010; 6
Weber (CR7) 2007; 13
Stupp (CR10) 2005; 352
Bergers, Hanahan (CR45) 2008; 8
Nakazawa (CR70) 2016; 7
Coniglio (CR16) 2012; 18
Pourcet, Pineda-Torra (CR25) 2013; 23
Mauer (CR26) 2014; 15
Sica, Mantovani (CR4) 2012; 122
Keith, Simon (CR29) 2007; 129
Bettelli (CR61) 2006; 441
Odegaard (CR37) 2007; 447
Quintana (CR68) 2013; 27
Wang (CR67) 2010; 465
Wesolowska (CR17) 2008; 27
Molnarfi (CR69) 2013; 210
Ostuni, Kratochvill, Murray, Natoli (CR3) 2015; 36
Pollard (CR1) 2004; 4
Murray, Wynn (CR5) 2011; 11
Ghajar (CR49) 2013; 15
A Szanto (3050_CR63) 2010; 33
GM Tannahill (3050_CR34) 2013; 496
X Liao (3050_CR64) 2011; 121
A Sica (3050_CR4) 2012; 122
N Molnarfi (3050_CR69) 2013; 210
CC Poon (3050_CR14) 2017; 140
MA Selak (3050_CR33) 2005; 7
3050_CR43
N Takeda (3050_CR36) 2010; 24
J Weissenberger (3050_CR54) 2004; 23
JI Odegaard (3050_CR37) 2007; 447
MC Ku (3050_CR21) 2013; 125
Y Komohara (3050_CR42) 2008; 216
MS Nakazawa (3050_CR70) 2016; 7
Y Fan (3050_CR35) 2014; 16
MS Weber (3050_CR7) 2007; 13
Z Cao (3050_CR52) 2014; 25
M Rincon (3050_CR60) 1997; 185
PJ Murray (3050_CR5) 2011; 11
GL Semenza (3050_CR30) 2012; 148
B Ruffell (3050_CR2) 2015; 27
C Calabrese (3050_CR47) 2007; 11
Y Wang (3050_CR67) 2010; 465
SJ Coniglio (3050_CR16) 2012; 18
B Keith (3050_CR29) 2007; 129
GP Dunn (3050_CR8) 2012; 26
M Rincon (3050_CR57) 2012; 33
JM Butler (3050_CR46) 2010; 10
A Omuro (3050_CR9) 2013; 310
A Quintana (3050_CR68) 2013; 27
J Mazumdar (3050_CR28) 2009; 13
D Hambardzumyan (3050_CR12) 2016; 19
M Ricote (3050_CR62) 1998; 391
G Bergers (3050_CR45) 2008; 8
CY Chang (3050_CR39) 2005; 12
M Stein (3050_CR6) 1992; 176
J Lu (3050_CR50) 2013; 23
B Beck (3050_CR44) 2011; 478
JH Park (3050_CR32) 2003; 9
CM Ghajar (3050_CR49) 2013; 15
B Pourcet (3050_CR25) 2013; 23
N Charles (3050_CR40) 2010; 6
JW Pollard (3050_CR1) 2004; 4
SM Pyonteck (3050_CR13) 2013; 19
AC Carvalho da Fonseca (3050_CR15) 2014; 274
K Vinnakota (3050_CR18) 2013; 15
R Stupp (3050_CR10) 2005; 352
SA Jones (3050_CR58) 2011; 121
R Ostuni (3050_CR3) 2015; 36
T Lawrence (3050_CR27) 2011; 11
H He (3050_CR53) 2012; 120
CA Hunter (3050_CR56) 2015; 16
J Mauer (3050_CR26) 2014; 15
RA Morantz (3050_CR11) 1979; 50
P Carmeliet (3050_CR48) 2011; 473
SM Weis (3050_CR51) 2011; 17
M Kopf (3050_CR55) 1994; 368
VV Sumbayev (3050_CR31) 2008; 582
MA Bouhlel (3050_CR38) 2007; 6
M Huang (3050_CR66) 2016; 126
A Hamidian (3050_CR65) 2015; 461
A Wesolowska (3050_CR17) 2008; 27
A Mantovani (3050_CR41) 2002; 23
FO Martinez (3050_CR22) 2014; 6
D Tugal (3050_CR24) 2013; 33
CA Fielding (3050_CR59) 2014; 40
M Sielska (3050_CR19) 2013; 230
E Bettelli (3050_CR61) 2006; 441
SC Wang (3050_CR20) 2012; 92
M Prosniak (3050_CR23) 2013; 19
References_xml – volume: 185
  start-page: 461
  year: 1997
  end-page: 469
  ident: CR60
  article-title: Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+T cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.185.3.461
– volume: 15
  start-page: 1457
  year: 2013
  end-page: 1468
  ident: CR18
  article-title: Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion
  publication-title: Neuro-Oncology
  doi: 10.1093/neuonc/not115
– volume: 6
  start-page: 137
  year: 2007
  end-page: 143
  ident: CR38
  article-title: PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2007.06.010
– volume: 216
  start-page: 15
  year: 2008
  end-page: 24
  ident: CR42
  article-title: Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
  publication-title: J. Pathol.
  doi: 10.1002/path.2370
– volume: 6
  start-page: 141
  year: 2010
  end-page: 152
  ident: CR40
  article-title: Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2010.01.001
– volume: 23
  start-page: 549
  year: 2002
  end-page: 555
  ident: CR41
  article-title: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
  publication-title: Trends Immunol.
  doi: 10.1016/S1471-4906(02)02302-5
– volume: 23
  start-page: 143
  year: 2013
  end-page: 152
  ident: CR25
  article-title: Transcriptional regulation of macrophage arginase 1 expression and its role in atherosclerosis
  publication-title: Trends Cardiovasc. Med.
  doi: 10.1016/j.tcm.2012.10.003
– volume: 11
  start-page: 723
  year: 2011
  end-page: 737
  ident: CR5
  article-title: Protective and pathogenic functions of macrophage subsets
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3073
– volume: 230
  start-page: 310
  year: 2013
  end-page: 321
  ident: CR19
  article-title: Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response
  publication-title: J. Pathol.
  doi: 10.1002/path.4192
– volume: 120
  start-page: 3152
  year: 2012
  end-page: 3162
  ident: CR53
  article-title: Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages
  publication-title: Blood
  doi: 10.1182/blood-2012-04-422758
– volume: 92
  start-page: 151
  year: 2012
  end-page: 162
  ident: CR20
  article-title: Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model
  publication-title: Lab Invest.
  doi: 10.1038/labinvest.2011.128
– volume: 461
  start-page: 560
  year: 2015
  end-page: 567
  ident: CR65
  article-title: Differential regulation of HIF-1alpha and HIF-2alpha in neuroblastoma: estrogen-related receptor alpha (ERRalpha) regulates HIF2A transcription and correlates to poor outcome
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2015.04.083
– volume: 27
  start-page: 918
  year: 2008
  end-page: 930
  ident: CR17
  article-title: Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210683
– volume: 17
  start-page: 1359
  year: 2011
  end-page: 1370
  ident: CR51
  article-title: Tumor angiogenesis: molecular pathways and therapeutic targets
  publication-title: Nat. Med.
  doi: 10.1038/nm.2537
– volume: 9
  start-page: 433
  year: 2003
  end-page: 440
  ident: CR32
  article-title: Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells
  publication-title: Clin. Cancer Res.
– volume: 8
  start-page: 592
  year: 2008
  end-page: 603
  ident: CR45
  article-title: Modes of resistance to anti-angiogenic therapy
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2442
– volume: 11
  start-page: 69
  year: 2007
  end-page: 82
  ident: CR47
  article-title: A perivascular niche for brain tumor stem cells
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.11.020
– volume: 24
  start-page: 491
  year: 2010
  end-page: 501
  ident: CR36
  article-title: Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis
  publication-title: Genes Dev.
  doi: 10.1101/gad.1881410
– volume: 148
  start-page: 399
  year: 2012
  end-page: 408
  ident: CR30
  article-title: Hypoxia-inducible factors in physiology and medicine
  publication-title: Cell
  doi: 10.1016/j.cell.2012.01.021
– volume: 50
  start-page: 305
  year: 1979
  end-page: 311
  ident: CR11
  article-title: Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors
  publication-title: J. Neurosurg.
  doi: 10.3171/jns.1979.50.3.0305
– volume: 13
  start-page: 4319
  year: 2009
  end-page: 4328
  ident: CR28
  article-title: Hypoxia-inducible factors in stem cells and cancer
  publication-title: J. Cell. Mol. Med
  doi: 10.1111/j.1582-4934.2009.00963.x
– volume: 19
  start-page: 20
  year: 2016
  end-page: 27
  ident: CR12
  article-title: The role of microglia and macrophages in glioma maintenance and progression
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn.4185
– volume: 441
  start-page: 235
  year: 2006
  end-page: 238
  ident: CR61
  article-title: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
  publication-title: Nature
  doi: 10.1038/nature04753
– volume: 6
  start-page: 13
  year: 2014
  ident: CR22
  article-title: The M1 and M2 paradigm of macrophage activation: time for reassessment
  publication-title: F1000prime Rep.
  doi: 10.12703/P6-13
– volume: 7
  start-page: 77
  year: 2005
  end-page: 85
  ident: CR33
  article-title: Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2004.11.022
– volume: 125
  start-page: 609
  year: 2013
  end-page: 620
  ident: CR21
  article-title: GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-013-1079-8
– volume: 496
  start-page: 238
  year: 2013
  end-page: 242
  ident: CR34
  article-title: Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha
  publication-title: Nature
  doi: 10.1038/nature11986
– volume: 19
  start-page: 3776
  year: 2013
  end-page: 3786
  ident: CR23
  article-title: Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-12-1940
– volume: 140
  start-page: 1548
  year: 2017
  end-page: 1560
  ident: CR14
  article-title: Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis
  publication-title: Brain
  doi: 10.1093/brain/aww355
– volume: 4
  start-page: 71
  year: 2004
  end-page: 78
  ident: CR1
  article-title: Tumour-educated macrophages promote tumour progression and metastasis
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1256
– volume: 176
  start-page: 287
  year: 1992
  end-page: 292
  ident: CR6
  article-title: Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.176.1.287
– volume: 121
  start-page: 2736
  year: 2011
  end-page: 2749
  ident: CR64
  article-title: Kruppel-like factor 4 regulates macrophage polarization
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI45444
– volume: 352
  start-page: 987
  year: 2005
  end-page: 996
  ident: CR10
  article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa043330
– volume: 391
  start-page: 79
  year: 1998
  end-page: 82
  ident: CR62
  article-title: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
  publication-title: Nature
  doi: 10.1038/34178
– volume: 16
  start-page: 445
  year: 2014
  end-page: 456
  ident: CR35
  article-title: Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1alpha accumulation
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb2954
– volume: 310
  start-page: 1842
  year: 2013
  end-page: 1850
  ident: CR9
  article-title: Glioblastoma and other malignant gliomas: a clinical review
  publication-title: JAMA
  doi: 10.1001/jama.2013.280319
– volume: 121
  start-page: 3375
  year: 2011
  end-page: 3383
  ident: CR58
  article-title: Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI57158
– volume: 36
  start-page: 229
  year: 2015
  end-page: 239
  ident: CR3
  article-title: Macrophages and cancer: from mechanisms to therapeutic implications
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2015.02.004
– volume: 274
  start-page: 71
  year: 2014
  end-page: 77
  ident: CR15
  article-title: Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2014.06.021
– ident: CR43
– volume: 473
  start-page: 298
  year: 2011
  end-page: 307
  ident: CR48
  article-title: Molecular mechanisms and clinical applications of angiogenesis
  publication-title: Nature
  doi: 10.1038/nature10144
– volume: 15
  start-page: 423
  year: 2014
  end-page: 430
  ident: CR26
  article-title: Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2865
– volume: 15
  start-page: 807
  year: 2013
  end-page: 817
  ident: CR49
  article-title: The perivascular niche regulates breast tumour dormancy
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb2767
– volume: 122
  start-page: 787
  year: 2012
  end-page: 795
  ident: CR4
  article-title: Macrophage plasticity and polarization: in vivo veritas
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI59643
– volume: 10
  start-page: 138
  year: 2010
  end-page: 146
  ident: CR46
  article-title: Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2791
– volume: 13
  start-page: 935
  year: 2007
  end-page: 943
  ident: CR7
  article-title: Type II monocytes modulate T cell-mediated central nervous system autoimmune disease
  publication-title: Nat. Med.
  doi: 10.1038/nm1620
– volume: 16
  start-page: 448
  year: 2015
  end-page: 457
  ident: CR56
  article-title: IL-6 as a keystone cytokine in health and disease
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3153
– volume: 478
  start-page: 399
  year: 2011
  end-page: 403
  ident: CR44
  article-title: A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours
  publication-title: Nature
  doi: 10.1038/nature10525
– volume: 7
  year: 2016
  ident: CR70
  article-title: Epigenetic re-expression of HIF-2alpha suppresses soft tissue sarcoma growth
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms10539
– volume: 23
  start-page: 171
  year: 2013
  end-page: 185
  ident: CR50
  article-title: Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of jagged-1
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.12.021
– volume: 465
  start-page: 483
  year: 2010
  end-page: 486
  ident: CR67
  article-title: Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis
  publication-title: Nature
  doi: 10.1038/nature09002
– volume: 26
  start-page: 756
  year: 2012
  end-page: 784
  ident: CR8
  article-title: Emerging insights into the molecular and cellular basis of glioblastoma
  publication-title: Genes Dev.
  doi: 10.1101/gad.187922.112
– volume: 210
  start-page: 2921
  year: 2013
  end-page: 2937
  ident: CR69
  article-title: MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20130699
– volume: 129
  start-page: 465
  year: 2007
  end-page: 472
  ident: CR29
  article-title: Hypoxia-inducible factors, stem cells, and cancer
  publication-title: Cell
  doi: 10.1016/j.cell.2007.04.019
– volume: 126
  start-page: 1801
  year: 2016
  end-page: 1814
  ident: CR66
  article-title: c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI84876
– volume: 33
  start-page: 1135
  year: 2013
  end-page: 1144
  ident: CR24
  article-title: Transcriptional control of macrophage polarization
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.113.301453
– volume: 23
  start-page: 3308
  year: 2004
  end-page: 3316
  ident: CR54
  article-title: IL-6 is required for glioma development in a mouse model
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207455
– volume: 368
  start-page: 339
  year: 1994
  end-page: 342
  ident: CR55
  article-title: Impaired immune and acute-phase responses in interleukin-6-deficient mice
  publication-title: Nature
  doi: 10.1038/368339a0
– volume: 33
  start-page: 571
  year: 2012
  end-page: 577
  ident: CR57
  article-title: Interleukin-6: from an inflammatory marker to a target for inflammatory diseases
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2012.07.003
– volume: 11
  start-page: 750
  year: 2011
  end-page: 761
  ident: CR27
  article-title: Transcriptional regulation of macrophage polarization: enabling diversity with identity
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3088
– volume: 12
  start-page: 930
  year: 2005
  end-page: 933
  ident: CR39
  article-title: Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme
  publication-title: J. Clin. Neurosci.
  doi: 10.1016/j.jocn.2004.11.017
– volume: 33
  start-page: 699
  year: 2010
  end-page: 712
  ident: CR63
  article-title: STAT6 transcription factor is a facilitator of the nuclear receptor PPARgamma-regulated gene expression in macrophages and dendritic cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2010.11.009
– volume: 18
  start-page: 519
  year: 2012
  end-page: 527
  ident: CR16
  article-title: Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling
  publication-title: Mol. Med.
  doi: 10.2119/molmed.2011.00217
– volume: 25
  start-page: 350
  year: 2014
  end-page: 365
  ident: CR52
  article-title: Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2014.02.005
– volume: 27
  start-page: 462
  year: 2015
  end-page: 472
  ident: CR2
  article-title: Macrophages and therapeutic resistance in cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.02.015
– volume: 582
  start-page: 319
  year: 2008
  end-page: 326
  ident: CR31
  article-title: LPS-induced Toll-like receptor 4 signalling triggers cross-talk of apoptosis signal-regulating kinase 1 (ASK1) and HIF-1alpha protein
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2007.12.024
– volume: 27
  start-page: 162
  year: 2013
  end-page: 173
  ident: CR68
  article-title: Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2012.10.011
– volume: 40
  start-page: 40
  year: 2014
  end-page: 50
  ident: CR59
  article-title: Interleukin-6 signaling drives fibrosis in unresolved inflammation
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.10.022
– volume: 19
  start-page: 1264
  year: 2013
  end-page: 1272
  ident: CR13
  article-title: CSF-1R inhibition alters macrophage polarization and blocks glioma progression
  publication-title: Nat. Med.
  doi: 10.1038/nm.3337
– volume: 447
  start-page: 1116
  year: 2007
  end-page: 1120
  ident: CR37
  article-title: Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance
  publication-title: Nature
  doi: 10.1038/nature05894
– volume: 33
  start-page: 699
  year: 2010
  ident: 3050_CR63
  publication-title: Immunity
  doi: 10.1016/j.immuni.2010.11.009
– ident: 3050_CR43
  doi: 10.1172/jci.insight.85841
– volume: 19
  start-page: 1264
  year: 2013
  ident: 3050_CR13
  publication-title: Nat. Med.
  doi: 10.1038/nm.3337
– volume: 27
  start-page: 162
  year: 2013
  ident: 3050_CR68
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2012.10.011
– volume: 473
  start-page: 298
  year: 2011
  ident: 3050_CR48
  publication-title: Nature
  doi: 10.1038/nature10144
– volume: 24
  start-page: 491
  year: 2010
  ident: 3050_CR36
  publication-title: Genes Dev.
  doi: 10.1101/gad.1881410
– volume: 122
  start-page: 787
  year: 2012
  ident: 3050_CR4
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI59643
– volume: 368
  start-page: 339
  year: 1994
  ident: 3050_CR55
  publication-title: Nature
  doi: 10.1038/368339a0
– volume: 9
  start-page: 433
  year: 2003
  ident: 3050_CR32
  publication-title: Clin. Cancer Res.
– volume: 120
  start-page: 3152
  year: 2012
  ident: 3050_CR53
  publication-title: Blood
  doi: 10.1182/blood-2012-04-422758
– volume: 15
  start-page: 423
  year: 2014
  ident: 3050_CR26
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2865
– volume: 23
  start-page: 549
  year: 2002
  ident: 3050_CR41
  publication-title: Trends Immunol.
  doi: 10.1016/S1471-4906(02)02302-5
– volume: 210
  start-page: 2921
  year: 2013
  ident: 3050_CR69
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20130699
– volume: 478
  start-page: 399
  year: 2011
  ident: 3050_CR44
  publication-title: Nature
  doi: 10.1038/nature10525
– volume: 176
  start-page: 287
  year: 1992
  ident: 3050_CR6
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.176.1.287
– volume: 23
  start-page: 143
  year: 2013
  ident: 3050_CR25
  publication-title: Trends Cardiovasc. Med.
  doi: 10.1016/j.tcm.2012.10.003
– volume: 12
  start-page: 930
  year: 2005
  ident: 3050_CR39
  publication-title: J. Clin. Neurosci.
  doi: 10.1016/j.jocn.2004.11.017
– volume: 230
  start-page: 310
  year: 2013
  ident: 3050_CR19
  publication-title: J. Pathol.
  doi: 10.1002/path.4192
– volume: 13
  start-page: 935
  year: 2007
  ident: 3050_CR7
  publication-title: Nat. Med.
  doi: 10.1038/nm1620
– volume: 352
  start-page: 987
  year: 2005
  ident: 3050_CR10
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa043330
– volume: 92
  start-page: 151
  year: 2012
  ident: 3050_CR20
  publication-title: Lab Invest.
  doi: 10.1038/labinvest.2011.128
– volume: 185
  start-page: 461
  year: 1997
  ident: 3050_CR60
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.185.3.461
– volume: 140
  start-page: 1548
  year: 2017
  ident: 3050_CR14
  publication-title: Brain
  doi: 10.1093/brain/aww355
– volume: 274
  start-page: 71
  year: 2014
  ident: 3050_CR15
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2014.06.021
– volume: 27
  start-page: 462
  year: 2015
  ident: 3050_CR2
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.02.015
– volume: 126
  start-page: 1801
  year: 2016
  ident: 3050_CR66
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI84876
– volume: 27
  start-page: 918
  year: 2008
  ident: 3050_CR17
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210683
– volume: 15
  start-page: 1457
  year: 2013
  ident: 3050_CR18
  publication-title: Neuro-Oncology
  doi: 10.1093/neuonc/not115
– volume: 121
  start-page: 3375
  year: 2011
  ident: 3050_CR58
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI57158
– volume: 4
  start-page: 71
  year: 2004
  ident: 3050_CR1
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1256
– volume: 441
  start-page: 235
  year: 2006
  ident: 3050_CR61
  publication-title: Nature
  doi: 10.1038/nature04753
– volume: 13
  start-page: 4319
  year: 2009
  ident: 3050_CR28
  publication-title: J. Cell. Mol. Med
  doi: 10.1111/j.1582-4934.2009.00963.x
– volume: 19
  start-page: 20
  year: 2016
  ident: 3050_CR12
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn.4185
– volume: 11
  start-page: 69
  year: 2007
  ident: 3050_CR47
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.11.020
– volume: 40
  start-page: 40
  year: 2014
  ident: 3050_CR59
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.10.022
– volume: 461
  start-page: 560
  year: 2015
  ident: 3050_CR65
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2015.04.083
– volume: 15
  start-page: 807
  year: 2013
  ident: 3050_CR49
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb2767
– volume: 26
  start-page: 756
  year: 2012
  ident: 3050_CR8
  publication-title: Genes Dev.
  doi: 10.1101/gad.187922.112
– volume: 11
  start-page: 750
  year: 2011
  ident: 3050_CR27
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3088
– volume: 391
  start-page: 79
  year: 1998
  ident: 3050_CR62
  publication-title: Nature
  doi: 10.1038/34178
– volume: 310
  start-page: 1842
  year: 2013
  ident: 3050_CR9
  publication-title: JAMA
  doi: 10.1001/jama.2013.280319
– volume: 125
  start-page: 609
  year: 2013
  ident: 3050_CR21
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-013-1079-8
– volume: 216
  start-page: 15
  year: 2008
  ident: 3050_CR42
  publication-title: J. Pathol.
  doi: 10.1002/path.2370
– volume: 6
  start-page: 137
  year: 2007
  ident: 3050_CR38
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2007.06.010
– volume: 23
  start-page: 3308
  year: 2004
  ident: 3050_CR54
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207455
– volume: 129
  start-page: 465
  year: 2007
  ident: 3050_CR29
  publication-title: Cell
  doi: 10.1016/j.cell.2007.04.019
– volume: 7
  year: 2016
  ident: 3050_CR70
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms10539
– volume: 50
  start-page: 305
  year: 1979
  ident: 3050_CR11
  publication-title: J. Neurosurg.
  doi: 10.3171/jns.1979.50.3.0305
– volume: 33
  start-page: 571
  year: 2012
  ident: 3050_CR57
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2012.07.003
– volume: 11
  start-page: 723
  year: 2011
  ident: 3050_CR5
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3073
– volume: 582
  start-page: 319
  year: 2008
  ident: 3050_CR31
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2007.12.024
– volume: 16
  start-page: 445
  year: 2014
  ident: 3050_CR35
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb2954
– volume: 16
  start-page: 448
  year: 2015
  ident: 3050_CR56
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3153
– volume: 8
  start-page: 592
  year: 2008
  ident: 3050_CR45
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2442
– volume: 10
  start-page: 138
  year: 2010
  ident: 3050_CR46
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2791
– volume: 25
  start-page: 350
  year: 2014
  ident: 3050_CR52
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2014.02.005
– volume: 447
  start-page: 1116
  year: 2007
  ident: 3050_CR37
  publication-title: Nature
  doi: 10.1038/nature05894
– volume: 23
  start-page: 171
  year: 2013
  ident: 3050_CR50
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.12.021
– volume: 6
  start-page: 141
  year: 2010
  ident: 3050_CR40
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2010.01.001
– volume: 148
  start-page: 399
  year: 2012
  ident: 3050_CR30
  publication-title: Cell
  doi: 10.1016/j.cell.2012.01.021
– volume: 465
  start-page: 483
  year: 2010
  ident: 3050_CR67
  publication-title: Nature
  doi: 10.1038/nature09002
– volume: 36
  start-page: 229
  year: 2015
  ident: 3050_CR3
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2015.02.004
– volume: 6
  start-page: 13
  year: 2014
  ident: 3050_CR22
  publication-title: F1000prime Rep.
  doi: 10.12703/P6-13
– volume: 7
  start-page: 77
  year: 2005
  ident: 3050_CR33
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2004.11.022
– volume: 33
  start-page: 1135
  year: 2013
  ident: 3050_CR24
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.113.301453
– volume: 19
  start-page: 3776
  year: 2013
  ident: 3050_CR23
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-12-1940
– volume: 18
  start-page: 519
  year: 2012
  ident: 3050_CR16
  publication-title: Mol. Med.
  doi: 10.2119/molmed.2011.00217
– volume: 121
  start-page: 2736
  year: 2011
  ident: 3050_CR64
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI45444
– volume: 496
  start-page: 238
  year: 2013
  ident: 3050_CR34
  publication-title: Nature
  doi: 10.1038/nature11986
– volume: 17
  start-page: 1359
  year: 2011
  ident: 3050_CR51
  publication-title: Nat. Med.
  doi: 10.1038/nm.2537
SSID ssj0000391844
Score 2.6116502
Snippet Spatiotemporal regulation of tumor immunity remains largely unexplored. Here we identify a vascular niche that controls alternative macrophage activation in...
Macrophages in the tumour microenvironment (TME) acquire tumour-promoting functions upon M2 polarization. Here the authors show, in a mouse model of...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 559
SubjectTerms 13/31
14/5
45/77
45/88
45/90
631/67/1922
631/67/327
64/110
96/1
Animals
Arginase
Arginase - immunology
Basic Helix-Loop-Helix Transcription Factors - genetics
Brain cancer
Cancer
Cancer therapies
Cell activation
Cell Line, Tumor
Cells, Cultured
Colony-stimulating factor
Cytokines
Disease Progression
Endothelial cells
Endothelial Cells - immunology
Flow cytometry
Glioblastoma
Glioblastoma - immunology
Growth factors
Human subjects
Humanities and Social Sciences
Humans
Hypoxia
Hypoxia-inducible factors
Immunity
Immunology
Interleukin 6
Interleukin-6 - immunology
Macrophage Activation - immunology
Macrophage colony-stimulating factor
Macrophage Colony-Stimulating Factor - immunology
Macrophages
Macrophages - immunology
Medicine
Mice
Microvessels - cytology
Monocytes - immunology
multidisciplinary
Neoplasms, Experimental - immunology
Neurosurgery
Nitric oxide
Otolaryngology
Peroxisome proliferator-activated receptors
Polarization
Polyamines
Radiation
Rodents
Science
Science (multidisciplinary)
Survival
Transcription activation
Transcriptional Activation
Tumor Microenvironment
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELZQJSQuiDcLpTISN7Dq56732KJGKUKcKOoFWX6FVmo3FUkP_Cz-CL-JGXsTJVDgwnXtKLPz8MzseL4h5JWe8WSTVKyNMjEtecd6RKAVMaQ-gca0Fe3zQzs90e9OzenGqC-8E1bhgSvj9s1MdT51nQ8zo6POto_ZgoEmRArzsfSRg8_bSKbKGax6SF302CXDld1f6HImcIEdZdxwxrc8UQHsvynK_P2y5C8V0-KIJvfI3TGCpAeV8vvkVh4ekNt1puS3h-Tzp_FuKR3wlic9fs9aCok3iHBBS218KFjf9NLj9K4zOE8oNjfUT7Owk365OJ8HCKqX80tPxzk-dHo8YfLH90fkZHL08e2UjTMUWDStXQLPRUo42RPSChFaK33Qyds8SzpxH4wPPPM-i5y8ShAMtMmqiDhqHYIGgK9_THaG-ZCfEgqyNsC5AAlT0jHHXqmcY4itkdonmxsiVvx0cQQYxzkXF64UupV1VQYOZOCKDBxvyOv1b64qvMZfdx-imNY7ERq7PACFcaPCuH8pTEN2V0J2o70unCh5H8Y7Ny7LHlJ5AfTA8sv1MhgiVlf8kOfXC5znKRDot1MNeVJVZk2o7EvDMvx3t6VMW2-yvTKcnxWwb2MRslI35M1K7Tao_iOnnv0PTj0nd2SxF8m43SU7y6_X-QWEYMuwV6ztJxBlLIs
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMQFQXkFCjISN7DqOE7snBAgVlsEnCjaC7L82rZSm5Rme-Bn8Uf4Tcw43sBC6XXtaBPPwzOe8fcR8lwuedBBVKzxIjApuGItItCW3oU2gMY0I9rnp2a-L98v6kU-cBtyW-XaJyZHHXqPZ-S7ooVsqpQQvb86_caQNQqrq5lC4yq5htBl2NKlFmo6Y0H0cy1lvivDK707yOQZeIn3ynjNGd_YjxJs_0Wx5r8tk3_VTdN2NLtNbuU4kr4eBX-HXIndNrk-Mkt-3yY3Puaa-V3y9UtuNqUdtn3SvQ-soZCJg0wHmorlXQL_picW6bwOwcFQvO0wntXCTHpwfNQ7iLJX_YmlmdiHzvdmTPz8cY_sz959fjtnmVSB-brRKxBCGQJSfUKeUbpGC-tksDougwzcuto6HnkbyxhsFSA6aIKuPAKrKUQRgM3_Ptnq-i4-JBSEX8MiOsiggvTRt1UVo3e-qYW0QceClOulNT4jjiPxxbFJle9Km1EcBsRhkjgML8iL6ZnTEW_j0tlvUGLTTMTKTj_0Zwcmm56pl5WyQSnrlrX0MurWRw0uPiDWnPWqIDtreZtswIMpUyKIAdCFw7-1sSDPpmGwTCy32C725wMSfJaI_KuqgjwYtWd6UdGmG8zw32pDrza-ZHOkOzpM6N-1RgxLWZCXaw38463_u1KPLv-Kx-SmSEYhGNc7ZGt1dh6fQLS1ck-TSf0Cmzwmsw
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaqVkhcEOUZKMhI3CDCrzjOsaxYbRHiRFEvyPJr20ptUnW3B34Wf4Tf1BnnIRYWJK4ZR5l4ZuwZe-YbQl6rJYsmClnqIGKpBKvLBhFoefCxiaAxukf7_KwXx-rjSXWyQ8RYC5OT9jOkZV6mx-ywdyuVTZpxLAhjFSshTN9D6HbU6pmeTecqiHhulBrqY5g0W17d2IMyVP82__LPNMnf7krzFjS_T-4NviM97LndJzupfUDu9N0kvz8k374OWaW0xfxOevSp1BRCbhDeiuZb8TajfNNLh327zmAloVjW0B_Kwkh6enHeeXCn192lo0MHH7o4mpfi549H5Hj-4ctsUQ7dE8pQabOG2eYxYk9PCCi410Y4r6IzaRlVZM5XzrPEmsRTdDKCG6CjkQER1GqEC4Bd_jHZbbs2PSUUpFzBzHkIlaIKKTRSphR80JVQLppUED7Opw0DtDh2uLiw-YpbGtvLwIIMbJaBZQV5M71z1QNr_HP0exTTNBJBsfOD7vrUDkpiq6WsXaxr55eVCiqZJiQDa3lEUDkX6oIcjEK2g6WuLM8RH3o6W8migSCeAz9AfjWRwQTxXsW1qbtZYSdPjhC_tSzIk15lJkZFk0uV4dv1hjJt_MkmpT0_yzDflUGwSlWQt6Pa_cL1X2fq2f8Nf07uimwZomTmgOyur2_SC3Cz1v5ltqtbuj0hNA
  priority: 102
  providerName: Springer Nature
Title Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α
URI https://link.springer.com/article/10.1038/s41467-018-03050-0
https://www.ncbi.nlm.nih.gov/pubmed/29422647
https://www.proquest.com/docview/1999660218
https://www.proquest.com/docview/2913314148
https://www.proquest.com/docview/2001065373
https://pubmed.ncbi.nlm.nih.gov/PMC5805734
https://doaj.org/article/5f37ad77abf54c4e89ce8111d4283ac7
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwED-NTUi8IP4TGJWReIOAkzix84BQV610FUwIKOoLsvyv26QugbaT2Mfii_CZODtJRaHjJZFiW3J8d_ad7fv9AJ6xGbXCpllcmNTGLKU8Lj0CbWK0LS1qTNGgfR4XowkbT_PpDnR0R-0ALreGdp5ParKYv_zx_fINGvzrJmVcvFqyYO408cliNKcxhvB7uDJxb6jvW3c_zMxZiQENa3Nntjf16MBlSC_lG0tVQPTf5ob-e5vyryPVsFINb8HN1sUk_UYnbsOOq-7A9YZ08vIufP3SXj4llb8GSo7exQXByBxlvCTh8LwKYODkXHl6r1OccIjPfmj2brEmOZmf1Rq97lV9rkhL9ENGR8M4_fXzHkyGh58Ho7glWYhNXogVCiWx1lN_YtyR6EKkSjOrhJtZZqnSudLU0dIlzqrMordQWJEZD7TGPaoAOgP3YbeqK_cQCCpDjoOoMaKyzDhTZplzRpsiT5mywkWQdOMpTYtA7okw5jKchGdCNuKQKA4ZxCFpBM_Xbb41-Bv_rX3gxbSu6bGzw4d6cSJbU5T5LOPKcq70LGeGOVEaJ3DKtx57ThkewX4nZNnpo0xCYOgdoq3FaYmxfoL9weKn62K0VH_8oipXXyw94WfikYB5FsGDRmXWHe1ULgK-oUwbf7JZUp2dBjTwXHhMSxbBi07t_uj1lSP16MouPIYbabCHNKZiH3ZXiwv3BB2vle7BNT7l-BTDtz3Y6_fHn8b4Pjg8_vARvw6KQS9safSC1f0GzXotQw
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIh4XBOUVKGAkOEFUx3ES54AQr9Uu3fbUol6QcWxvW6lNSncr1D-FxB_hNzHjJAsLpbdeY-_G8bw9nm8AnskJd8qJNM6tcLEUvIhLQqBNbOVKhxyTt2ifm_lwW37cyXaW4HtfC0PXKnudGBS1ayydka-JEqOpRKL3_vroa0xdoyi72rfQaNli3Z9-w5Bt-mr0Hun7XIjBh613w7jrKhDbLFczXEXiHPW6REc7qXIlTCWdUX7ipOOmykzFPS994p1JHZrH3KnUErJYQWX0aP3wfy_BZTS8nCSq2CnmZzqEtq6k7GpzeKrWpjJoIp5QHRvPeMwX7F9oE3CWb_vvFc2_8rTB_A1uwo3Ob2VvWka7BUu-XoErbSfL0xW4utHl6G_D50_d5VZW0zVTNhrHOcPIH3loykJyvg5g4-zQUPuwPVRojKor2rNhnMl2D_abCr36WXNoWNdIiA1Hg1j8_HEHti9ku-_Cct3U_j4wZLYMN7HCiM1J622Zpt7byuaZkMYpH0HSb622HcI5Ndo40CHTnirdkkMjOXQgh-YRvJj_5qjF9zh39lui2HwmYXOHB83xru5EXWeTtDCuKEw1yaSVXpXWKzQpjrDtjC0iWO3prTuFMdVJCDzJ4Tpz-Df3R_B0PoyagNI7pvbNyZQaiiaENFykEdxruWe-UFGGiml8d7HAVwtfsjhS7-8FtPFMEWamjOBlz4F_rPq_O_Xg_K94AteGWxtjPR5trj-E6yIIiIi5WoXl2fGJf4Se3qx6HMSLwZeLludf6NJkSg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKERUXBOUvUMBIcIJoHceJnQNCQFnt0lJxoGgvyDi2067UJqW7FepjceUheCZmnGRhofTWa-zdOJ5fe2a-IeSJqJhTjqdxbrmLBWcyLhCBNrGlKxxwTN6ife7ko13xbpJNVsiPvhYG0yp7nRgUtWss3pEPeAGnqUSA9z6ourSID5vDl0dfY-wghZHWvp1GyyJb_vQbHN9mL8abQOunnA_ffnwzirsOA7HNcjWHFSXOYd9LcLqTMlfclMIZ5SsnHDNlZkrmWeET70zqwFTmTqUWUcYkltSDJYT_vUQuyzRLUMbkRC7udxB5XQnR1emwVA1mImgllmBNG8tYzJZsYWgZcJaf-2-65l8x22AKh9fJtc6Hpa9aprtBVny9Tq60XS1P18na-y5ef5N8_tQlutIaU07peDvO6bR2wE8zGgL1dQAep4cGW4ntg3KjWGnR3hPDTLp3MG1K8PDnzaGhXVMhOhoPY_7z-y2yeyHbfZus1k3t7xIKjJfBJpZwenPCelukqfe2tHnGhXHKRyTpt1bbDu0cm24c6BB1T5VuyaGBHDqQQ7OIPFv85qjF-jh39muk2GIm4nSHB83xnu7EXmdVKo2T0pRVJqzwqrBegXlxiHNnrIzIRk9v3SmPmU7CIRSdrzOHf0tCRB4vhkErYKjH1L45mWFz0QRRh2UakTst9ywWyotQPQ3vlkt8tfQlyyP1dD8gj2cK8TNFRJ73HPjHqv-7U_fO_4pHZA0kWW-Pd7buk6s8yAePmdogq_PjE_8AnL55-TBIFyVfLlqcfwGa5WiA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vascular+niche+IL-6+induces+alternative+macrophage+activation+in+glioblastoma+through+HIF-2%CE%B1&rft.jtitle=Nature+communications&rft.au=Wang%2C+Qirui&rft.au=He%2C+Zhenqiang&rft.au=Huang%2C+Menggui&rft.au=Liu%2C+Tianrun&rft.date=2018-02-08&rft.eissn=2041-1723&rft.volume=9&rft.issue=1&rft.spage=559&rft_id=info:doi/10.1038%2Fs41467-018-03050-0&rft_id=info%3Apmid%2F29422647&rft.externalDocID=29422647
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon